DJ Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. $(NVAX)$ slipped 2.16% to $9.98 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.60% to 25,466.19 and the Dow Jones Industrial Average rising 0.49% to 52,486.49.

This was the stock's second consecutive day of losses.

Novavax Inc. closed 25.44% below its 52-week high of $13.39, which the company achieved on October 5th.

The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.13% to $280.41, Pfizer Inc. $(PFE)$ rose 0.31% to $29.45, and Merck & Co. Inc. (MRK) fell 0.59% to $147.18.

Trading volume (5.9 M) remained 1.2 million below its 50-day average volume of 7.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 11, 2026.